EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	34.06B
Revenue (ttm)	8.77B
Net Income (ttm)	1.02B
Shares Out	685.26M
EPS (ttm)	1.49
PE Ratio	33.27
Forward PE	n/a
Dividend	1.75 (3.52%)
Ex-Dividend Date	May 14, 2025

Volume	2,170,615
Average Volume	2,194,894
Open	49.72
Previous Close	49.70
Day's Range	49.54 - 50.20
52-Week Range	37.20 - 64.80
Beta	0.09
RSI	72.23
Earnings Date	Apr 29, 2025

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing. Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management. The company was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,088
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2024, IST:ECILC's revenue was 8.77 billion, a decrease of -6.28% compared to the previous year's 9.36 billion. Earnings were 1.02 billion, a decrease of -74.12%.